Effect of psychological Treatment on Diabetes

The Study of the Efficacy of Coping-Therapy and Acceptance and Commitment Therapy (ACT) on Biological and Psychological Indices of Patients with Type II Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017022132706N1

Enrollment

Registered

2017-05-06

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. diabetes (mellitus)(nonobese)(obese): adult-onset maturity-onset nonketotic stable type II

Interventions

Intervention 1: Intervention group1: Coping Therapy Treatment. Intervention 2: Intervention group 2: Acceptance and Commitment Therapy. Intervention 3: Control group:Diabetes Inhibition.

Treatment - Other

Lifestyle

Intervention group1: Coping Therapy Treatment

Intervention group 2: Acceptance and Commitment Therapy

Control group:Diabetes Inhibition

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria :Confirmation of Disease ; Patient' s Satisfication Exclusion Criteria: Psychiatric Diseases and Treatment for it ; Distatisfication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
FBS. Timepoint: Once in 2 Weeks. Method of measurement: Blood Sample.;2HPP. Timepoint: Once in 2 Weeks. Method of measurement: Blood Sample.;HBA1C. Timepoint: First and Endof Study. Method of measurement: Blood Sample.;Stress. Timepoint: First and End of Study. Method of measurement: Questionnair Coping With Stress.;Life Events and Changes in Family Life. Timepoint: First and end of study. Method of measurement: The Family Inventory of Life Events and Changes (FILE).;Quality of Life in Diabetic Patients. Timepoint: First and End of Study. Method of measurement: Questionnair Diabetes Quality of Life.;Locus of control. Timepoint: first and end of study. Method of measurement: Rotter "s locus of control sacle.;Commitment to treatment. Timepoint: first and end of study. Method of measurement: questionnair commitment to treatment.	—

Measure

Time frame

FBS. Timepoint: Once in 2 Weeks. Method of measurement: Blood Sample.;2HPP. Timepoint: Once in 2 Weeks. Method of measurement: Blood Sample.;HBA1C. Timepoint: First and Endof Study. Method of measurement: Blood Sample.;Stress. Timepoint: First and End of Study. Method of measurement: Questionnair Coping With Stress.;Life Events and Changes in Family Life. Timepoint: First and end of study. Method of measurement: The Family Inventory of Life Events and Changes (FILE).;Quality of Life in Diabetic Patients. Timepoint: First and End of Study. Method of measurement: Questionnair Diabetes Quality of Life.;Locus of control. Timepoint: first and end of study. Method of measurement: Rotter "s locus of control sacle.;Commitment to treatment. Timepoint: first and end of study. Method of measurement: questionnair commitment to treatment.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParastoo Abaspour

Kermanshah University of Medical Sciences

kcounselingcenter@kums.ac.ir; Pabaspour@yahoo.com+98 83 3827 3963

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026